Eli Lilly#39;s CEO David Ricks told Reuters on Wednesday that the U.S. drugmaker expects to launch its obesity drug in Indian market as early as next year.
Eli Lilly CEO David Ricks says its obesity drug could enter India as early as 2025
Estimated read time
1 min read